Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma
Conditions
Childhood Astrocytoma · Childhood Diffuse Intrinsic Pontine Glioma · Childhood Diffuse Midline Glioma · Childhood Glioblastoma · Childhood Malignant Glioma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Children's Hospital of Alabama, Birmingham, Alabama, United States
Contact: Principal Investigator (Girish Dhall)Children's Hospital Los Angeles, Los Angeles, California, United States
Contact: Principal Investigator (Fariba Navid)Children's Hospital of Orange County, Orange, California, United States
Contact: Principal Investigator (Josephine H. Haduong)UCSF Medical Center-Mission Bay, San Francisco, California, United States
Contact: Principal Investigator (Kieuhoa T. Vo)Children's Hospital Colorado, Aurora, Colorado, United States
Contact: Principal Investigator (Margaret E. Macy)Children's National Medical Center, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Site Public Contact) · OncCRC_OnCall@childrensnational.org · 202-476-2800Contact: Principal Investigator (AeRang Kim)Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States
Contact: Principal Investigator (Jason R. Fangusaro)Lurie Children's Hospital-Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Alicia Lenzen)Riley Hospital for Children, Indianapolis, Indiana, United States
Contact: Principal Investigator (Brian D. Weiss)C S Mott Children's Hospital, Ann Arbor, Michigan, United States
Contact: Principal Investigator (Rajen Mody)University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Robin L. Williams)Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Shalini Shenoy)NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162Contact: Principal Investigator (Nobuko Hijiya)Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Joseph G. Pressey)Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Cassie Kline)Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Andrew Bukowinski)Saint Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Principal Investigator (Dana Tlais)Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Jennifer H. Foster)UMC Cancer Center / UMC Health System, Lubbock, Texas, United States
Contact: Principal Investigator (Erin K. Barr)Seattle Children's Hospital, Seattle, Washington, United States
Contact: Principal Investigator (Katherine G. Tarlock)
Study leads
Erin K Barr
Principal Investigator
Pediatric Early Phase Clinical Trial Network